Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog

Exclusive Updates From Elsevier's Top Thought Leaders Provide Insight on Healthcare Reform and ARRA Momentum

PHILADELPHIA, Pennsylvania, November 30 - Elsevier, a world leader in healthcare
publications/information as well as web-based and electronic health record
(EHR) integrated solutions, today announced a new online resource center for
American Recovery and Reinvestment Act (ARRA) updates and initiatives.
Accessible via Elsevier's ClinicalDecisionSupport.com site, or by going to
www.clinicaldecisionsupport.com/ARRA, the resource center and
accompanying blog provide users with updates on ARRA progress and actions, as
well as insightful commentary on emerging trends and issues from top Elsevier
executives Jonathan Teich, M.D., Ph.D.; Michelle Troseth, RN, MSN, DPNAP; and
Swati Abbott, MS.

Meaningful clinical decision support (CDS) is a key tenet of
healthcare reform and ARRA goals for quality improvement. Designed to assist
physicians and other care providers with decisions at the point-of-care, CDS
systems assimilate data on a variety of conditions and diagnoses and can flag
potential issues, such as unsafe medication interactions, that may end up
being harmful to patients as well as costly to the entire healthcare system.

"Elsevier's CDS blog and ARRA portal are designed to be a
solution to the challenge of keeping current with national quality
initiatives, meaningful use updates, and other significant new policies and
programs that affect providers, payers, and patients," said Dr. Teich,
Elsevier's Chief Medical Informatics Officer. "The blog will be a way to
facilitate discussions on many topics relevant to the market today, including
the role of CDS in the national healthcare environment."

Elsevier has been a leader in the CDS industry for many years.
Elsevier's Consult Suite (i.e., First Consult, MD Consult, Nursing Consult)
and Gold Standard/Elsevier drug information products make knowledge
accessible via the EHR so physicians, nurses and pharmacists can make better
clinical decisions within the workflow and at the point of care. Elsevier's
CPM Resource Center (CPMRC) provides a well-tested framework including
integrated evidence-based interdisciplinary content and transformational
services at the point of care. CPMRC has an active international healthcare
consortium that co-creates clinician- and patient-focused CDS tools and
resources for healthcare transformation. In addition, through MEDai, Elsevier
delivers a patient-specific, real-time clinical surveillance solution that is
driven by predictive analytics to identify a patient's risk for re-admission
and hospital-acquired infection while the patient is still in the hospital.
The MEDai Pinpoint Suite, including the newly launched Pinpoint Review(R),
offers clinicians greater insight at the point of care, resulting in a higher
quality of care for both patient and provider.

Elsevier's blog is launching with introductory postings from
Michelle Troseth, Executive Vice President and Chief Professional Practice
Officer, CPMRC, and Swati Abbott, President of MEDai. Troseth's first blog
post discusses the "meaningful use" matrix and addresses considerations for
healthcare leaders and organizations today, while Abbott's entry highlights
common ailments and some possible solutions for our healthcare system,
especially with regard to technology. Readers can expect regular updates to
the blog as well as guest blog entries from leading industry executives.

"Elsevier understands the significance of ARRA and the demands
and opportunities it presents for hospitals and other care-providing
facilities," continued Teich. "We see ourselves as a partner to healthcare
executives and point of care clinicians who seek expert commentary and
feedback on the changing healthcare landscape."

About Elsevier

Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (www.thelancet.com) and Cell
(www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com),
Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and
Nursing Consult (www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(www.scival.com) and MEDai's Pinpoint Review (www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier
(www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Tom Reller, Vice President, Global Corporate Relations,
+1-215-239-3508, T.Reller@Elsevier.com

Tom Reller, Vice President, Global Corporate Relations, +1-215-239-3508, T.Reller at Elsevier.com